Long noncoding RNA MALAT1 may be a prognostic biomarker in IDH1/2 wild-type primary glioblastomas
Primary glioblastoma (GB) is the most aggressive type of brain tumors. While mutations in isocitrate dehydrogenase (IDH) genes are frequent in secondary GBs and correlate with a better prognosis, most primary GBs are IDH wild-type. Recent studies have shown that the long noncoding RNA metastasis as...
Main Authors: | Omer Gokay Argadal, Melis Mutlu, Secil Ak Aksoy, Hasan Kocaeli, Berrin Tunca, Muhammet Nafi Civan, Unal Egeli, Gulsah Cecener, Ahmet Bekar, Mevlut Ozgur Taskapilioglu, Cagla Tekin, Gulcin Tezcan, Sahsine Tolunay |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2020-02-01
|
Series: | Biomolecules & Biomedicine |
Subjects: | |
Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/4297 |
Similar Items
-
<i>Olea europaea</i> Leaf Phenolics Oleuropein, Hydroxytyrosol, Tyrosol, and Rutin Induce Apoptosis and Additionally Affect Temozolomide against Glioblastoma: In Particular, Oleuropein Inhibits Spheroid Growth by Attenuating Stem-like Cell Phenotype
by: Melis Ercelik, et al.
Published: (2023-02-01) -
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
by: Mathieu Simonin, et al.
Published: (2021-05-01) -
CYTOTOXIC ACTIVITY OF ROSMARINIC ACID ISOLATED FROM Prunella vulgaris L. AND Prunella grandiflora L. IN DIFFERENT TUMOR CELLS
by: Gülçin Tezcan, et al.
Published: (2017-03-01) -
IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution
by: Erika F. Rodriguez, et al.
Published: (2020-06-01) -
Ivosidenib, an IDH1 inhibitor, in a patient with recurrent, IDH1-mutant glioblastoma: a case report from a Phase I study
by: Dalissa Tejera, et al.
Published: (2020-09-01)